{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T18:07:18Z","timestamp":1776535638155,"version":"3.51.2"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T00:00:00Z","timestamp":1309392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s15010-011-0148-y","type":"journal-article","created":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T11:58:11Z","timestamp":1309348691000},"page":"583-585","source":"Crossref","is-referenced-by-count":16,"title":["A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia"],"prefix":"10.1007","volume":"39","author":[{"given":"C.","family":"Rether","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Conen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Grossenbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. C.","family":"Albrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,30]]},"reference":[{"key":"148_CR1","doi-asserted-by":"crossref","unstructured":"Hawkey PM. Pre-clinical experience with daptomycin. J Antimicrob Chemother. 2008; 62: iii7\u201314.","DOI":"10.1093\/jac\/dkn367"},{"issue":"8","key":"148_CR2","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","volume":"47","author":"JA Silverman","year":"2003","unstructured":"Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother. 2003;47(8):2538\u201344.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"148_CR3","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1086\/430352","volume":"191","author":"JA Silverman","year":"2005","unstructured":"Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis. 2005;191(12):2149\u201352.","journal-title":"J Infect Dis"},{"issue":"12","key":"148_CR4","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/504379","volume":"42","author":"S Papadopoulos","year":"2006","unstructured":"Papadopoulos S, Ball AM, Liewer SE, Martin CA, Winstead PS, Murphy BS. Rhabdomyolysis during therapy with daptomycin. Clin Infect Dis. 2006;42(12):e108\u201310.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"148_CR5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1345\/aph.1H372","volume":"41","author":"E Cobb","year":"2007","unstructured":"Cobb E, Kimbrough RC, Nugent KM, Phy MP. Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin. Ann Pharmacother. 2007;41(4):696\u2013701.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"148_CR6","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jinf.2006.11.006","volume":"54","author":"D Hayes Jr","year":"2007","unstructured":"Hayes D Jr, Anstead MI, Kuhn RJ. Eosinophilic pneumonia induced by daptomycin. J Infect. 2007;54(4):e211\u20133.","journal-title":"J Infect"},{"issue":"5","key":"148_CR7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/650487","volume":"50","author":"Y Lal","year":"2010","unstructured":"Lal Y, Assimacopoulos AP. Two cases of daptomycin-induced eosinophilic pneumonia and chronic pneumonitis. Clin Infect Dis. 2010;50(5):737\u201340.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"148_CR8","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1086\/652656","volume":"50","author":"BA Miller","year":"2010","unstructured":"Miller BA, Gray A, Leblanc TW, Sexton DJ, Martin AR, Slama TG. Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases. Clin Infect Dis. 2010;50(11):e63\u20138.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"148_CR9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jinf.2008.11.001","volume":"58","author":"A Shinde","year":"2009","unstructured":"Shinde A, Seifi A, DelRe S, Moustafa Hussein WH, Ohebsion J. Daptomycin-induced pulmonary infiltrates with eosinophilia. J Infect. 2009;58(2):173\u20134.","journal-title":"J Infect"},{"issue":"1","key":"148_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1752-1947-5-13","volume":"5","author":"AS Kalogeropoulos","year":"2011","unstructured":"Kalogeropoulos AS, Tsiodras S, Loverdos D, Fanourgiakis P, Skoutelis A. Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature. J Med Case Reports. 2011;5(1):13.","journal-title":"J Med Case Reports"},{"issue":"32","key":"148_CR11","first-page":"2172","volume":"172","author":"TS Sondergaard","year":"2010","unstructured":"Sondergaard TS, Schumacher H, Norup K. Possible daptomycin-induced organizing pneumonia. Ugeskr Laeger. 2010;172(32):2172\u20134.","journal-title":"Ugeskr Laeger"},{"issue":"2","key":"148_CR12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2006-939522","volume":"27","author":"J Solomon","year":"2006","unstructured":"Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med. 2006;27(2):192\u20137.","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"148_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0272-5231(03)00141-2","volume":"25","author":"JN Allen","year":"2004","unstructured":"Allen JN. Drug-induced eosinophilic lung disease. Clin Chest Med. 2004;25(1):77\u201388.","journal-title":"Clin Chest Med"},{"issue":"2","key":"148_CR14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-011-0148-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-011-0148-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-011-0148-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T14:04:07Z","timestamp":1560348247000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-011-0148-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,30]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["148"],"URL":"https:\/\/doi.org\/10.1007\/s15010-011-0148-y","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,30]]}}}